Maternal vitals and labs in pregnancy: Difference between revisions
No edit summary
 
(24 intermediate revisions by 5 users not shown)
Line 1: Line 1:
==Vitals==
{{Pregnancy vitals}}
{| class="wikitable"
{{Pregnancy physiology}}
|-
{{Pregnancy labs}}
|
| '''Nonpregnat'''
| '''1st Trimester'''
| '''2nd Trimester'''
| '''3rd Trimester'''
|-
| HR
| 70
| 78
| 82
| 85
|-
| SBP
| 115
| 112
| 112
| 114
|-
| DBP
| 70
| 60
| 63
| 70
|-
| Hcrt
| 40
| 36
| 33
| 34
|-
| WBC
| 7.2k
| 9.1k
| 9.7k
| 9.8k
|}


==Labs==
==See Also==
*Increased ESR ~78
*[[Vital signs]]
*Decreased PaCO2 ~30
*ECG w/ Qs in III & aVF, L axis
*[[Beta-HCG Levels]]
*Decreased Hct
*Decreased BUN and creatinine
*Decreased Bicarb
*Increased WBC count
*Decreased PLTs
*Increased D-dimer and Fibrinogen
 
==Source==
*Rosen's


==References==
<references/>
[[Category:Critical Care]]
[[Category:Critical Care]]
[[Category:OB/GYN]]
[[Category:OBGYN]]

Latest revision as of 21:22, 4 December 2024

Normal Vitals in Pregnancy[1]

Vital Nonpregnant 1st Trimester 2nd Trimester 3rd Trimester
HR 70 78 82 85
SBP 115 112 112 114
DBP 70 60 63 70
Hcrt 40 36 33 34
WBC 7.2k 9.1k 9.7k 9.8k

Physiologic Changes in Pregnancy[2]

  • Heart rate (HR) increases 15-20 bpm (75-95 bpm)
  • Mean arterial pressure (MAP) increases 10 mmHg (80 mmHg)
  • Tidal volume (TV) increases 40% (700 cc)
  • Minute volume (MV) increases 40% (10.5 L/min)
  • Functional residual capacity (FRC) decreases 25% (1300ml)

Maternal Laboratory Changes in Pregnancy[3]

  • CBC
    • Increased WBC count (5k-15k)
    • Decreased hematocrit (32-34%) due to increased plasma volume
    • Decreased platelets
  • Chemistry
    • Decreased BUN and creatinine (<0.8mg/dL)
    • GFR increases up to 60% (140ml/min)
    • Decreased Bicarb
  • Other
    • Increased D-dimer and Fibrinogen
    • Increased ESR ~78
    • Decreased PaCO2 ~30
  • ECG with Qs in III & aVF, left axis
  • Beta-HCG Levels

See Also

References

  1. ↑ Kuklina EV, Ayala C, Callaghan WM. Hypertensive disorders and severe obstetric morbidity in the United States. Obstet Gynecol 2009; 113:1299-1306.
  2. ↑ Kuklina EV, Ayala C, Callaghan WM. Hypertensive disorders and severe obstetric morbidity in the United States. Obstet Gynecol 2009; 113:1299-1306.
  3. ↑ Kuklina EV, Ayala C, Callaghan WM. Hypertensive disorders and severe obstetric morbidity in the United States. Obstet Gynecol 2009; 113:1299-1306.
Retrieved from "https://www.wikem.org/w/index.php?title=Maternal_vitals_and_labs_in_pregnancy&oldid=375176"